Sort
39,280 grants matching “leukemia”
Modeling and correcting human SCID using patient-derived iPS cells
$569,518Luigi Daniele Notarangelo · Boston Children'S Hospital · R01 · FY2014 · AI
Modeling and correcting human SCID using patient-derived iPS cells
$569,518Luigi Daniele Notarangelo · Boston Children'S Hospital · R01 · FY2015 · AI
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$569,494Susan L Slager · Mayo Clinic Rochester · U01 · FY2014 · CA
ITIM-receptors for cancer treatment
$569,405Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Targeting the Ig-light chains with CAR-T cells in lymphoid tumors
$569,255Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Targeting the Ig-light chains with CAR-T cells in lymphoid tumors
$569,255Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
$569,213Jun J. Yang · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Mitotic roles of Nuclear Pore Complex (NPC) proteins
$569,183Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Tissue Core
$569,094Laura Z Rassenti · University Of California, San Diego · P01 · FY2012 · CA
Development of ASH1L inhibitors for acute leukemia
$568,956Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Genomics of childhood acute lymphoblastic leukemia in the Childhood Cancer and Leukemia International Consortium
$568,919Logan G Spector · University Of Minnesota · R01 · FY2023 · CA
Viscoelasticity and T Cell Production
$568,911David J Mooney · Harvard University · R01 · FY2023 · CA
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$568,895Jing Zhang · University Of Wisconsin-Madison · R01 · FY2020 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$568,895Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
$568,893Robert Coleman Lindsley · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Immunotherapy of low grade lymphoid malignancies
$568,871Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Mitotic roles of Nuclear Pore Complex (NPC) proteins
$568,853Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
RNA associated mechanisms for antigen receptor gene diversification during immature B cell development
$568,537Uttiya Basu · Columbia University Health Sciences · R01 · FY2025 · AI
RNA associated mechanisms for antigen receptor gene diversification during immature B cell development
$568,537Uttiya Basu · Columbia University Health Sciences · R01 · FY2024 · AI
SIGNAL TRANSDUCTION BY TYROSINE PHOSPHORYLATION
$568,509Salk Institute For Biological Studies · R01 · FY2001 · CA
A Proteogenomic Analysis of Platelets in Patients with Essential Thrombocythemia
$568,447David J Kuter · Massachusetts General Hospital · R01 · FY2008 · HL
Gene Therapy for Canine X-linked SCID
$568,337Peter J Felsburg · University Of Pennsylvania · R01 · FY2007 · AI
Regulation of Hematopoietic Progenitors by de novo DNA methylation
$568,203Margaret Goodell · Baylor College Of Medicine · R01 · FY2017 · DK
Regulation of Hematopoietic Progenitors by de novo DNA methylation
$568,203Margaret Goodell · Baylor College Of Medicine · R01 · FY2016 · DK
Adoptive immunotherapy after umbilical cord blood transplant
$568,179Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA